Since its establishment, the company has always insisted on relying on the drive of scientific and technological innovation. With the dedicated efforts of a multi-disciplinary and multi-category professional R&D team led by returning doctors, it has formed anti-tumor drugs, anti-viral drugs, cardiovascular drugs and senile dementia drugs. High-end characteristic raw material drug product system in therapeutic fields. The company has established "Jiangsu Province Major Disease Molecular Precision Targeting Drug Engineering Technology Research Center", "Jiangsu Province Postgraduate Workstation", "Suzhou Municipal New Pharmaceutical Anti-tumor Drug Engineering Technology Research Center" and "Suzhou Enterprise Technology Center" and other provinces and cities A level innovative R&D platform carrier, with Soochow University, Suzhou University of Science and Technology, Shanghai University of Engineering Technology, Suzhou Vocational University and Jiangnan University, etc. through the establishment of joint laboratories, school-enterprise joint practice bases and other forms to achieve industry-university-research integration. Continuous process optimization and quality improvement, the products have passed the NMPA technical review and GMP compliance inspection, and some key products have passed the on-site audit of the US FDA and the EU EDQM.